[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fqh2F7traM8vbjoUg8uNrCAKesJBy_HCzAmFB6KDrGjQ":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":35,"phaseBuckets":71,"rows":78},"Bispebjerg Hospital",[4],287,false,39,6,675550,14,219,[14,17,20,23,25,28,30,32],{"name":15,"count":16},"Asthma",17,{"name":18,"count":19},"Sarcopenia",9,{"name":21,"count":22},"Obesity",8,{"name":24,"count":22},"Tendinopathy",{"name":26,"count":27},"Stroke",7,{"name":29,"count":9},"Cancer",{"name":31,"count":9},"Hernia, Ventral",{"name":33,"count":34},"Muscle Loss",5,[36,41,46,51,56,61,66],{"nctId":37,"briefTitle":38,"date":39,"intervention":40},"NCT04232358","Resistance Training and Injection Treatment for Achilles Enthesopathy","2024-11-04","Corticosteroid",{"nctId":42,"briefTitle":43,"date":44,"intervention":45},"NCT06555146","Semaglutide's Effect on Renal Hemodynamics and Function in Patients With Type 2 Diabetes Mellitus and Nephropathy","2025-03","Semaglutide, 0.5 mg\u002FmL",{"nctId":47,"briefTitle":48,"date":49,"intervention":50},"NCT03778554","Danish Trial of Beta Blocker Treatment After Myocardial Infarction Without Reduced Ejection Fraction","2025-04-01","Metoprolol Succinate",{"nctId":52,"briefTitle":53,"date":54,"intervention":55},"NCT06274151","Optimal Treatment of Acute Skeletal Muscle Injury","2025-07-31","Naproxen 500 Mg",{"nctId":57,"briefTitle":58,"date":59,"intervention":60},"NCT05746650","Improving Tissue Repair After Injury in the Muscle-tendon Interface Muscle Tissue Injury","2027-06-01","Growth hormone",{"nctId":62,"briefTitle":63,"date":64,"intervention":65},"NCT06872060","The Effects of Glucagon on Renal Regional Blood Flow in Humans Measured by Magnetic Resonance.","2027-11-01","Glucagon",{"nctId":67,"briefTitle":68,"date":69,"intervention":70},"NCT03984591","A Registry-based Cluster Randomized Trial to Compare the Effect of Spironolactone vs. Eplerenone on Clinical Outcomes in Patients With Symptomatic Systolic Heart Failure","2028-12-31","Eplerenone",[72,73,74,75,76,77],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[79,109,127,145,163,186,204,242,277,300,318,340,362,380,398,434,460,478,502,526,550,576,600,622,647,679,707,731,749,776,794,812,837,861,886,908,926,951,976,1001,1025,1050,1075,1093,1120,1138,1161,1179,1204,1229,1254,1279,1303,1330,1348,1375,1403,1428,1446,1469,1521,1558,1587,1611,1629,1654,1677,1702,1720,1746,1770,1794,1812,1837,1860,1883,1907,1925,1950,1975,1993,2015,2040,2063,2081],{"intervention":50,"totalTrials":80,"cells":81},1,{"EARLY_PHASE1":82,"PHASE1":85,"PHASE2":87,"PHASE3":89,"PHASE4":91,"NA":107},{"trials":83,"activeCount":84},[],0,{"trials":86,"activeCount":84},[],{"trials":88,"activeCount":84},[],{"trials":90,"activeCount":84},[],{"trials":92,"activeCount":80,"soonestReadout":49},[93],{"nctId":47,"briefTitle":48,"status":94,"phases":95,"primaryCompletion":49,"completion":96,"start":97,"enrollment":98,"conditions":99,"interventions":103},"ACTIVE_NOT_RECRUITING",[76],"2035-12-10","2018-12-17",2760,[100,101,102],"Acute Myocardial Infarction","Non-ST Elevation Myocardial Infarction (nSTEMI)","ST Elevation Myocardial Infarction",[50,104,105,106],"Bisoprolol","Carvedilol","Nebivolol",{"trials":108,"activeCount":84},[],{"intervention":104,"totalTrials":80,"cells":110},{"EARLY_PHASE1":111,"PHASE1":113,"PHASE2":115,"PHASE3":117,"PHASE4":119,"NA":125},{"trials":112,"activeCount":84},[],{"trials":114,"activeCount":84},[],{"trials":116,"activeCount":84},[],{"trials":118,"activeCount":84},[],{"trials":120,"activeCount":80,"soonestReadout":49},[121],{"nctId":47,"briefTitle":48,"status":94,"phases":122,"primaryCompletion":49,"completion":96,"start":97,"enrollment":98,"conditions":123,"interventions":124},[76],[100,101,102],[50,104,105,106],{"trials":126,"activeCount":84},[],{"intervention":105,"totalTrials":80,"cells":128},{"EARLY_PHASE1":129,"PHASE1":131,"PHASE2":133,"PHASE3":135,"PHASE4":137,"NA":143},{"trials":130,"activeCount":84},[],{"trials":132,"activeCount":84},[],{"trials":134,"activeCount":84},[],{"trials":136,"activeCount":84},[],{"trials":138,"activeCount":80,"soonestReadout":49},[139],{"nctId":47,"briefTitle":48,"status":94,"phases":140,"primaryCompletion":49,"completion":96,"start":97,"enrollment":98,"conditions":141,"interventions":142},[76],[100,101,102],[50,104,105,106],{"trials":144,"activeCount":84},[],{"intervention":106,"totalTrials":80,"cells":146},{"EARLY_PHASE1":147,"PHASE1":149,"PHASE2":151,"PHASE3":153,"PHASE4":155,"NA":161},{"trials":148,"activeCount":84},[],{"trials":150,"activeCount":84},[],{"trials":152,"activeCount":84},[],{"trials":154,"activeCount":84},[],{"trials":156,"activeCount":80,"soonestReadout":49},[157],{"nctId":47,"briefTitle":48,"status":94,"phases":158,"primaryCompletion":49,"completion":96,"start":97,"enrollment":98,"conditions":159,"interventions":160},[76],[100,101,102],[50,104,105,106],{"trials":162,"activeCount":84},[],{"intervention":70,"totalTrials":80,"cells":164},{"EARLY_PHASE1":165,"PHASE1":167,"PHASE2":169,"PHASE3":171,"PHASE4":173,"NA":184},{"trials":166,"activeCount":84},[],{"trials":168,"activeCount":84},[],{"trials":170,"activeCount":84},[],{"trials":172,"activeCount":84},[],{"trials":174,"activeCount":80,"soonestReadout":69},[175],{"nctId":67,"briefTitle":68,"status":176,"phases":177,"primaryCompletion":69,"completion":69,"start":178,"enrollment":179,"conditions":180,"interventions":182},"ENROLLING_BY_INVITATION",[76],"2020-11-01",7200,[181],"Systolic Heart Failure",[70,183],"Spironolactone",{"trials":185,"activeCount":84},[],{"intervention":183,"totalTrials":80,"cells":187},{"EARLY_PHASE1":188,"PHASE1":190,"PHASE2":192,"PHASE3":194,"PHASE4":196,"NA":202},{"trials":189,"activeCount":84},[],{"trials":191,"activeCount":84},[],{"trials":193,"activeCount":84},[],{"trials":195,"activeCount":84},[],{"trials":197,"activeCount":80,"soonestReadout":69},[198],{"nctId":67,"briefTitle":68,"status":176,"phases":199,"primaryCompletion":69,"completion":69,"start":178,"enrollment":179,"conditions":200,"interventions":201},[76],[181],[70,183],{"trials":203,"activeCount":84},[],{"intervention":55,"totalTrials":205,"cells":206},2,{"EARLY_PHASE1":207,"PHASE1":209,"PHASE2":211,"PHASE3":213,"PHASE4":215,"NA":217},{"trials":208,"activeCount":84},[],{"trials":210,"activeCount":84},[],{"trials":212,"activeCount":84},[],{"trials":214,"activeCount":84},[],{"trials":216,"activeCount":84},[],{"trials":218,"activeCount":80,"soonestReadout":54},[219,229],{"nctId":52,"briefTitle":53,"status":220,"phases":221,"primaryCompletion":54,"completion":222,"start":223,"enrollment":224,"conditions":225,"interventions":228},"NOT_YET_RECRUITING",[77],"2029-12-31","2024-02-15",20,[226,227],"Muscle Strain, Multiple Sites","Inflammation",[55],{"nctId":230,"briefTitle":231,"status":232,"phases":233,"primaryCompletion":234,"completion":235,"start":236,"enrollment":237,"conditions":238,"interventions":241},"NCT03401177","Treatment of Early Phase Achilles Tendinopathy - the Effect of NSAIDs","COMPLETED",[77],"2019-07-31","2020-04-27","2018-01-15",70,[239,240,227],"Tendon Injuries","Achilles Tendinopathy",[55],{"intervention":243,"totalTrials":205,"cells":244},"Sodium chloride",{"EARLY_PHASE1":245,"PHASE1":247,"PHASE2":249,"PHASE3":251,"PHASE4":265,"NA":267},{"trials":246,"activeCount":84},[],{"trials":248,"activeCount":84},[],{"trials":250,"activeCount":84},[],{"trials":252,"activeCount":84},[253],{"nctId":254,"briefTitle":255,"status":232,"phases":256,"primaryCompletion":257,"completion":258,"start":259,"enrollment":260,"conditions":261,"interventions":263},"NCT00524381","Etanercept Treatment in the Early Course of Polymyalgia Rheumatica",[75],"2009-07","2009-09","2007-08",40,[262],"Polymyalgia Rheumatica",[264,243],"Etanercept",{"trials":266,"activeCount":84},[],{"trials":268,"activeCount":80,"soonestReadout":64},[269],{"nctId":62,"briefTitle":63,"status":220,"phases":270,"primaryCompletion":64,"completion":64,"start":271,"enrollment":272,"conditions":273,"interventions":275},[77],"2026-06-01",10,[274],"Kidney Diseases",[65,276,243],"Glucagon+Exendin9-39",{"intervention":40,"totalTrials":80,"cells":278},{"EARLY_PHASE1":279,"PHASE1":281,"PHASE2":283,"PHASE3":285,"PHASE4":287,"NA":289},{"trials":280,"activeCount":84},[],{"trials":282,"activeCount":84},[],{"trials":284,"activeCount":84},[],{"trials":286,"activeCount":84},[],{"trials":288,"activeCount":84},[],{"trials":290,"activeCount":80,"soonestReadout":39},[291],{"nctId":37,"briefTitle":38,"status":94,"phases":292,"primaryCompletion":39,"completion":293,"start":294,"enrollment":295,"conditions":296,"interventions":298},[77],"2025-05-04","2021-05-04",50,[297],"Achilles Entesopathy",[40,299],"Local anesthesia injections",{"intervention":299,"totalTrials":80,"cells":301},{"EARLY_PHASE1":302,"PHASE1":304,"PHASE2":306,"PHASE3":308,"PHASE4":310,"NA":312},{"trials":303,"activeCount":84},[],{"trials":305,"activeCount":84},[],{"trials":307,"activeCount":84},[],{"trials":309,"activeCount":84},[],{"trials":311,"activeCount":84},[],{"trials":313,"activeCount":80,"soonestReadout":39},[314],{"nctId":37,"briefTitle":38,"status":94,"phases":315,"primaryCompletion":39,"completion":293,"start":294,"enrollment":295,"conditions":316,"interventions":317},[77],[297],[40,299],{"intervention":60,"totalTrials":80,"cells":319},{"EARLY_PHASE1":320,"PHASE1":322,"PHASE2":324,"PHASE3":326,"PHASE4":328,"NA":330},{"trials":321,"activeCount":84},[],{"trials":323,"activeCount":84},[],{"trials":325,"activeCount":84},[],{"trials":327,"activeCount":84},[],{"trials":329,"activeCount":84},[],{"trials":331,"activeCount":80,"soonestReadout":59},[332],{"nctId":57,"briefTitle":58,"status":333,"phases":334,"primaryCompletion":59,"completion":335,"start":336,"enrollment":260,"conditions":337,"interventions":339},"RECRUITING",[77],"2027-09-01","2023-02-24",[338],"Muscle Injury",[60],{"intervention":45,"totalTrials":80,"cells":341},{"EARLY_PHASE1":342,"PHASE1":344,"PHASE2":346,"PHASE3":348,"PHASE4":350,"NA":352},{"trials":343,"activeCount":84},[],{"trials":345,"activeCount":84},[],{"trials":347,"activeCount":84},[],{"trials":349,"activeCount":84},[],{"trials":351,"activeCount":84},[],{"trials":353,"activeCount":80,"soonestReadout":44},[354],{"nctId":42,"briefTitle":43,"status":220,"phases":355,"primaryCompletion":44,"completion":44,"start":356,"enrollment":357,"conditions":358,"interventions":361},[77],"2024-08",15,[359,360],"Diabetes Mellitus, Type 2","Kidney Disease, Chronic",[45],{"intervention":65,"totalTrials":80,"cells":363},{"EARLY_PHASE1":364,"PHASE1":366,"PHASE2":368,"PHASE3":370,"PHASE4":372,"NA":374},{"trials":365,"activeCount":84},[],{"trials":367,"activeCount":84},[],{"trials":369,"activeCount":84},[],{"trials":371,"activeCount":84},[],{"trials":373,"activeCount":84},[],{"trials":375,"activeCount":80,"soonestReadout":64},[376],{"nctId":62,"briefTitle":63,"status":220,"phases":377,"primaryCompletion":64,"completion":64,"start":271,"enrollment":272,"conditions":378,"interventions":379},[77],[274],[65,276,243],{"intervention":276,"totalTrials":80,"cells":381},{"EARLY_PHASE1":382,"PHASE1":384,"PHASE2":386,"PHASE3":388,"PHASE4":390,"NA":392},{"trials":383,"activeCount":84},[],{"trials":385,"activeCount":84},[],{"trials":387,"activeCount":84},[],{"trials":389,"activeCount":84},[],{"trials":391,"activeCount":84},[],{"trials":393,"activeCount":80,"soonestReadout":64},[394],{"nctId":62,"briefTitle":63,"status":220,"phases":395,"primaryCompletion":64,"completion":64,"start":271,"enrollment":272,"conditions":396,"interventions":397},[77],[274],[65,276,243],{"intervention":399,"totalTrials":205,"cells":400},"Methylphenidate",{"EARLY_PHASE1":401,"PHASE1":403,"PHASE2":405,"PHASE3":407,"PHASE4":409,"NA":432},{"trials":402,"activeCount":84},[],{"trials":404,"activeCount":84},[],{"trials":406,"activeCount":84},[],{"trials":408,"activeCount":84},[],{"trials":410,"activeCount":84},[411,422],{"nctId":412,"briefTitle":413,"status":232,"phases":414,"primaryCompletion":415,"start":416,"enrollment":417,"conditions":418,"interventions":421},"NCT02147535","Impact of CES1 Genotype on Metabolism of Methylphenidate",[76],"2014-08","2014-03",78,[419,420],"Carboxylesterase 1 (CES1) Genotype","CES1 Activity",[399],{"nctId":423,"briefTitle":424,"status":232,"phases":425,"primaryCompletion":426,"completion":426,"start":427,"enrollment":428,"conditions":429,"interventions":430},"NCT02135263","Metabolism of Methylphenidate and Enalapril Based on CES1 Genotype",[76],"2014-05","2012-04",44,[419,420],[399,431],"Enalapril",{"trials":433,"activeCount":84},[],{"intervention":435,"totalTrials":80,"cells":436},"No curettage",{"EARLY_PHASE1":437,"PHASE1":439,"PHASE2":441,"PHASE3":443,"PHASE4":445,"NA":458},{"trials":438,"activeCount":84},[],{"trials":440,"activeCount":84},[],{"trials":442,"activeCount":84},[],{"trials":444,"activeCount":84},[],{"trials":446,"activeCount":84},[447],{"nctId":448,"briefTitle":449,"status":232,"phases":450,"primaryCompletion":451,"completion":451,"start":452,"enrollment":453,"conditions":454,"interventions":456},"NCT03697590","Photodynamic Therapy of Actinic Keratosis of the Face and Scalp With and Without Prior Curettage",[76],"2017-12-20","2017-06-01",25,[455],"Keratosis, Actinic",[435,457],"Curettage",{"trials":459,"activeCount":84},[],{"intervention":457,"totalTrials":80,"cells":461},{"EARLY_PHASE1":462,"PHASE1":464,"PHASE2":466,"PHASE3":468,"PHASE4":470,"NA":476},{"trials":463,"activeCount":84},[],{"trials":465,"activeCount":84},[],{"trials":467,"activeCount":84},[],{"trials":469,"activeCount":84},[],{"trials":471,"activeCount":84},[472],{"nctId":448,"briefTitle":449,"status":232,"phases":473,"primaryCompletion":451,"completion":451,"start":452,"enrollment":453,"conditions":474,"interventions":475},[76],[455],[435,457],{"trials":477,"activeCount":84},[],{"intervention":479,"totalTrials":80,"cells":480},"Seretide",{"EARLY_PHASE1":481,"PHASE1":483,"PHASE2":485,"PHASE3":487,"PHASE4":489,"NA":500},{"trials":482,"activeCount":84},[],{"trials":484,"activeCount":84},[],{"trials":486,"activeCount":84},[],{"trials":488,"activeCount":84},[],{"trials":490,"activeCount":84},[491],{"nctId":492,"briefTitle":493,"status":232,"phases":494,"primaryCompletion":495,"completion":495,"start":496,"enrollment":497,"conditions":498,"interventions":499},"NCT00262587","Elite Sport and Development of Asthma",[76],"2008-12","2005-09",18,[15],[479],{"trials":501,"activeCount":84},[],{"intervention":503,"totalTrials":80,"cells":504},"ODACTRA 12 SQ-HDM Sublingual",{"EARLY_PHASE1":505,"PHASE1":507,"PHASE2":509,"PHASE3":511,"PHASE4":513,"NA":524},{"trials":506,"activeCount":84},[],{"trials":508,"activeCount":84},[],{"trials":510,"activeCount":84},[],{"trials":512,"activeCount":84},[],{"trials":514,"activeCount":84},[515],{"nctId":516,"briefTitle":517,"status":232,"phases":518,"primaryCompletion":519,"completion":519,"start":520,"enrollment":8,"conditions":521,"interventions":523},"NCT04100902","The Effect of Allergen Immunotherapy on Anti-viral Immunity in Patients With Allergic Asthma",[76],"2022-02-27","2020-01-20",[522],"Allergic Asthma Due to Dermatophagoides Pteronyssinus",[503],{"trials":525,"activeCount":84},[],{"intervention":527,"totalTrials":80,"cells":528},"inhaled salmeterol",{"EARLY_PHASE1":529,"PHASE1":531,"PHASE2":533,"PHASE3":535,"PHASE4":537,"NA":548},{"trials":530,"activeCount":84},[],{"trials":532,"activeCount":84},[],{"trials":534,"activeCount":84},[],{"trials":536,"activeCount":84},[],{"trials":538,"activeCount":84},[539],{"nctId":540,"briefTitle":541,"status":542,"phases":543,"primaryCompletion":544,"completion":544,"start":257,"enrollment":545,"conditions":546,"interventions":547},"NCT00914901","Concentrations of Salmeterol in Blood and Urine","UNKNOWN",[76],"2011-03",30,[15],[527],{"trials":549,"activeCount":84},[],{"intervention":551,"totalTrials":80,"cells":552},"Glucocorticosteroid",{"EARLY_PHASE1":553,"PHASE1":555,"PHASE2":557,"PHASE3":559,"PHASE4":561,"NA":574},{"trials":554,"activeCount":84},[],{"trials":556,"activeCount":84},[],{"trials":558,"activeCount":84},[],{"trials":560,"activeCount":84},[],{"trials":562,"activeCount":84},[563],{"nctId":564,"briefTitle":565,"status":232,"phases":566,"primaryCompletion":567,"completion":568,"start":569,"enrollment":570,"conditions":571,"interventions":573},"NCT01994759","Optimal Treatment of Plantar Fasciitis: Physical Training, Glucocorticoid Injections or a Combination Thereof.",[76],"2015-07-01","2016-12-01","2013-09-01",90,[572],"Plantar Fasciitis",[551],{"trials":575,"activeCount":84},[],{"intervention":577,"totalTrials":80,"cells":578},"Budesonide",{"EARLY_PHASE1":579,"PHASE1":581,"PHASE2":583,"PHASE3":585,"PHASE4":587,"NA":598},{"trials":580,"activeCount":84},[],{"trials":582,"activeCount":84},[],{"trials":584,"activeCount":84},[],{"trials":586,"activeCount":84},[],{"trials":588,"activeCount":84},[589],{"nctId":590,"briefTitle":591,"status":232,"phases":592,"primaryCompletion":593,"completion":593,"start":594,"enrollment":595,"conditions":596,"interventions":597},"NCT03034005","The RECONSTRUCT Study - Reconstructing Disease Mechanisms in Asthma",[76],"2019-02-28","2017-03-27",60,[15],[577],{"trials":599,"activeCount":84},[],{"intervention":601,"totalTrials":80,"cells":602},"inhaled formoterol",{"EARLY_PHASE1":603,"PHASE1":605,"PHASE2":607,"PHASE3":609,"PHASE4":611,"NA":620},{"trials":604,"activeCount":84},[],{"trials":606,"activeCount":84},[],{"trials":608,"activeCount":84},[],{"trials":610,"activeCount":84},[],{"trials":612,"activeCount":84},[613],{"nctId":614,"briefTitle":615,"status":542,"phases":616,"primaryCompletion":617,"completion":617,"start":257,"enrollment":545,"conditions":618,"interventions":619},"NCT00914654","Concentrations of Formoterol in Blood and Urine",[76],"2010-12",[15],[601],{"trials":621,"activeCount":84},[],{"intervention":623,"totalTrials":80,"cells":624},"Treatment with either metoprolol or carvedilol",{"EARLY_PHASE1":625,"PHASE1":627,"PHASE2":629,"PHASE3":631,"PHASE4":633,"NA":645},{"trials":626,"activeCount":84},[],{"trials":628,"activeCount":84},[],{"trials":630,"activeCount":84},[],{"trials":632,"activeCount":84},[],{"trials":634,"activeCount":84},[635],{"nctId":636,"briefTitle":637,"status":232,"phases":638,"completion":639,"start":640,"enrollment":295,"conditions":641,"interventions":644},"NCT00497003","Effect of Beta Blocker Treatment on Endothelial Function in Patients With Type 2 Diabetes or Chronic Heart Failure",[76],"2007-10","2004-02",[642,643],"Endothelial Function","Beta Blocker",[623],{"trials":646,"activeCount":84},[],{"intervention":648,"totalTrials":80,"cells":649},"Azithromycin",{"EARLY_PHASE1":650,"PHASE1":652,"PHASE2":654,"PHASE3":656,"PHASE4":658,"NA":677},{"trials":651,"activeCount":84},[],{"trials":653,"activeCount":84},[],{"trials":655,"activeCount":84},[],{"trials":657,"activeCount":84},[],{"trials":659,"activeCount":84},[660],{"nctId":661,"briefTitle":662,"status":542,"phases":663,"primaryCompletion":664,"completion":665,"start":666,"enrollment":667,"conditions":668,"interventions":676},"NCT04319705","Anti-viral Effects of Azithromycin in Patients With Asthma and COPD",[76],"2022-03-31","2022-12-31","2020-03-02",100,[15,669,670,671,672,673,674,675],"COPD","Exacerbation Copd","Asthma; Eosinophilic","Bronchial Diseases","Lung Diseases, Obstructive","Lung Diseases","Immune System Diseases",[648],{"trials":678,"activeCount":84},[],{"intervention":680,"totalTrials":80,"cells":681},"Viscous Lidocaine",{"EARLY_PHASE1":682,"PHASE1":684,"PHASE2":686,"PHASE3":688,"PHASE4":690,"NA":705},{"trials":683,"activeCount":84},[],{"trials":685,"activeCount":84},[],{"trials":687,"activeCount":84},[],{"trials":689,"activeCount":84},[],{"trials":691,"activeCount":84},[692],{"nctId":693,"briefTitle":694,"status":695,"phases":696,"primaryCompletion":697,"completion":698,"start":699,"enrollment":700,"conditions":701,"interventions":704},"NCT04725695","Preoperative Viscous Lidocaine for Upper Gastrointestinal Endoscopy","TERMINATED",[76],"2023-12-15","2024-10-30","2022-03-29",119,[702,703],"Anesthetics, Local","Esophagogastroduodenoscopy",[680],{"trials":706,"activeCount":84},[],{"intervention":708,"totalTrials":80,"cells":709},"Ultrasound guided injection with Glucocorticosteroid",{"EARLY_PHASE1":710,"PHASE1":712,"PHASE2":714,"PHASE3":716,"PHASE4":718,"NA":729},{"trials":711,"activeCount":84},[],{"trials":713,"activeCount":84},[],{"trials":715,"activeCount":84},[],{"trials":717,"activeCount":84},[],{"trials":719,"activeCount":84},[720],{"nctId":721,"briefTitle":722,"status":232,"phases":723,"primaryCompletion":724,"completion":724,"start":725,"enrollment":667,"conditions":726,"interventions":727},"NCT02580630","Achilles Tendinopathy Treated With Training and Injections",[76],"2020-12-20","2016-04",[240],[708,728],"Ultrasound guided injection with local anaestethic",{"trials":730,"activeCount":84},[],{"intervention":728,"totalTrials":80,"cells":732},{"EARLY_PHASE1":733,"PHASE1":735,"PHASE2":737,"PHASE3":739,"PHASE4":741,"NA":747},{"trials":734,"activeCount":84},[],{"trials":736,"activeCount":84},[],{"trials":738,"activeCount":84},[],{"trials":740,"activeCount":84},[],{"trials":742,"activeCount":84},[743],{"nctId":721,"briefTitle":722,"status":232,"phases":744,"primaryCompletion":724,"completion":724,"start":725,"enrollment":667,"conditions":745,"interventions":746},[76],[240],[708,728],{"trials":748,"activeCount":84},[],{"intervention":750,"totalTrials":80,"cells":751},"nerve block with ropivacaine",{"EARLY_PHASE1":752,"PHASE1":754,"PHASE2":756,"PHASE3":758,"PHASE4":760,"NA":774},{"trials":753,"activeCount":84},[],{"trials":755,"activeCount":84},[],{"trials":757,"activeCount":84},[],{"trials":759,"activeCount":84},[],{"trials":761,"activeCount":84},[762],{"nctId":763,"briefTitle":764,"status":232,"phases":765,"primaryCompletion":766,"completion":766,"start":767,"enrollment":768,"conditions":769,"interventions":771},"NCT02465827","Ultrasound-guided Selective Blockade of the Saphenous and Obturator Nerves Following Total Knee Arthroplasty",[76],"2015-03","2014-01",75,[770],"Knee Arthroplasty, Total",[750,772,773],"nerve block with ropivacaine and with saline","nerve block with saline",{"trials":775,"activeCount":84},[],{"intervention":772,"totalTrials":80,"cells":777},{"EARLY_PHASE1":778,"PHASE1":780,"PHASE2":782,"PHASE3":784,"PHASE4":786,"NA":792},{"trials":779,"activeCount":84},[],{"trials":781,"activeCount":84},[],{"trials":783,"activeCount":84},[],{"trials":785,"activeCount":84},[],{"trials":787,"activeCount":84},[788],{"nctId":763,"briefTitle":764,"status":232,"phases":789,"primaryCompletion":766,"completion":766,"start":767,"enrollment":768,"conditions":790,"interventions":791},[76],[770],[750,772,773],{"trials":793,"activeCount":84},[],{"intervention":773,"totalTrials":80,"cells":795},{"EARLY_PHASE1":796,"PHASE1":798,"PHASE2":800,"PHASE3":802,"PHASE4":804,"NA":810},{"trials":797,"activeCount":84},[],{"trials":799,"activeCount":84},[],{"trials":801,"activeCount":84},[],{"trials":803,"activeCount":84},[],{"trials":805,"activeCount":84},[806],{"nctId":763,"briefTitle":764,"status":232,"phases":807,"primaryCompletion":766,"completion":766,"start":767,"enrollment":768,"conditions":808,"interventions":809},[76],[770],[750,772,773],{"trials":811,"activeCount":84},[],{"intervention":813,"totalTrials":80,"cells":814},"Botulinum Toxin A",{"EARLY_PHASE1":815,"PHASE1":817,"PHASE2":819,"PHASE3":821,"PHASE4":823,"NA":835},{"trials":816,"activeCount":84},[],{"trials":818,"activeCount":84},[],{"trials":820,"activeCount":84},[],{"trials":822,"activeCount":84},[],{"trials":824,"activeCount":84},[825],{"nctId":826,"briefTitle":827,"status":232,"phases":828,"primaryCompletion":829,"completion":829,"start":830,"enrollment":272,"conditions":831,"interventions":834},"NCT05426161","The Effect of Subcutaneous Injection of Botulinum Toxin A on Chronic Wound Pain in Lower Extremities",[76],"2024-04-23","2023-02-07",[832,833],"Chronic Pain","Lower Extremity Wound",[813],{"trials":836,"activeCount":84},[],{"intervention":838,"totalTrials":80,"cells":839},"Escitalopram",{"EARLY_PHASE1":840,"PHASE1":842,"PHASE2":844,"PHASE3":846,"PHASE4":848,"NA":859},{"trials":841,"activeCount":84},[],{"trials":843,"activeCount":84},[],{"trials":845,"activeCount":84},[],{"trials":847,"activeCount":84},[],{"trials":849,"activeCount":84},[850],{"nctId":851,"briefTitle":852,"status":542,"phases":853,"primaryCompletion":495,"start":854,"enrollment":855,"conditions":856,"interventions":858},"NCT00140257","DECARD: Study of Escitalopram in the Prevention of Depression in Patients With Acute Coronary Syndrome",[76],"2004-11",240,[857],"Depression",[838],{"trials":860,"activeCount":84},[],{"intervention":862,"totalTrials":80,"cells":863},"Eflornithine cream 11.5 w\u002Fw %",{"EARLY_PHASE1":864,"PHASE1":866,"PHASE2":868,"PHASE3":870,"PHASE4":872,"NA":884},{"trials":865,"activeCount":84},[],{"trials":867,"activeCount":84},[],{"trials":869,"activeCount":84},[],{"trials":871,"activeCount":84},[],{"trials":873,"activeCount":84},[874],{"nctId":875,"briefTitle":876,"status":232,"phases":877,"primaryCompletion":878,"completion":878,"start":879,"enrollment":880,"conditions":881,"interventions":883},"NCT01817894","Treatment With Topical Eflornithin After Laser Treatment in Women With Facial Hirsutism",[76],"2013-10","2012-01",22,[882],"Hirsutism",[862],{"trials":885,"activeCount":84},[],{"intervention":887,"totalTrials":80,"cells":888},"inhaled and oral terbutaline",{"EARLY_PHASE1":889,"PHASE1":891,"PHASE2":893,"PHASE3":895,"PHASE4":897,"NA":906},{"trials":890,"activeCount":84},[],{"trials":892,"activeCount":84},[],{"trials":894,"activeCount":84},[],{"trials":896,"activeCount":84},[],{"trials":898,"activeCount":84},[899],{"nctId":900,"briefTitle":901,"status":542,"phases":902,"primaryCompletion":903,"completion":903,"start":257,"enrollment":545,"conditions":904,"interventions":905},"NCT00914797","Terbutaline Concentrations in Blood and Urine",[76],"2010-03",[15],[887],{"trials":907,"activeCount":84},[],{"intervention":431,"totalTrials":80,"cells":909},{"EARLY_PHASE1":910,"PHASE1":912,"PHASE2":914,"PHASE3":916,"PHASE4":918,"NA":924},{"trials":911,"activeCount":84},[],{"trials":913,"activeCount":84},[],{"trials":915,"activeCount":84},[],{"trials":917,"activeCount":84},[],{"trials":919,"activeCount":84},[920],{"nctId":423,"briefTitle":424,"status":232,"phases":921,"primaryCompletion":426,"completion":426,"start":427,"enrollment":428,"conditions":922,"interventions":923},[76],[419,420],[399,431],{"trials":925,"activeCount":84},[],{"intervention":927,"totalTrials":80,"cells":928},"Cholecalciferol",{"EARLY_PHASE1":929,"PHASE1":931,"PHASE2":933,"PHASE3":935,"PHASE4":937,"NA":949},{"trials":930,"activeCount":84},[],{"trials":932,"activeCount":84},[],{"trials":934,"activeCount":84},[],{"trials":936,"activeCount":84},[],{"trials":938,"activeCount":84},[939],{"nctId":940,"briefTitle":941,"status":232,"phases":942,"primaryCompletion":943,"completion":944,"start":879,"enrollment":945,"conditions":946,"interventions":948},"NCT02186106","Dosage Calculation for Vitamin D Treatment",[76],"2013-06","2013-09",31,[947,21],"Deficiency, Vitamin D",[927],{"trials":950,"activeCount":84},[],{"intervention":952,"totalTrials":80,"cells":953},"Sildenafil",{"EARLY_PHASE1":954,"PHASE1":956,"PHASE2":958,"PHASE3":960,"PHASE4":962,"NA":974},{"trials":955,"activeCount":84},[],{"trials":957,"activeCount":84},[],{"trials":959,"activeCount":84},[],{"trials":961,"activeCount":84},[],{"trials":963,"activeCount":84},[964],{"nctId":965,"briefTitle":966,"status":232,"phases":967,"primaryCompletion":640,"completion":968,"start":969,"enrollment":22,"conditions":970,"interventions":973},"NCT01941732","Motor Response to Sildenafil in PD",[76],"2004-03","2003-11",[971,972],"Parkinsons Disease","Erectile Dysfunction",[952],{"trials":975,"activeCount":84},[],{"intervention":977,"totalTrials":80,"cells":978},"Ramipril",{"EARLY_PHASE1":979,"PHASE1":981,"PHASE2":983,"PHASE3":985,"PHASE4":987,"NA":999},{"trials":980,"activeCount":84},[],{"trials":982,"activeCount":84},[],{"trials":984,"activeCount":84},[],{"trials":986,"activeCount":84},[],{"trials":988,"activeCount":84},[989],{"nctId":990,"briefTitle":991,"status":232,"phases":992,"primaryCompletion":993,"completion":993,"start":994,"enrollment":995,"conditions":996,"interventions":998},"NCT02525081","Effect of ACE-Inhibition on Microvascular Function in Women With Assessed Microvascular Dysfunction",[76],"2016-07","2015-07",63,[997],"Microvascular Angina",[977],{"trials":1000,"activeCount":84},[],{"intervention":1002,"totalTrials":80,"cells":1003},"prednisone",{"EARLY_PHASE1":1004,"PHASE1":1006,"PHASE2":1008,"PHASE3":1010,"PHASE4":1012,"NA":1023},{"trials":1005,"activeCount":84},[],{"trials":1007,"activeCount":84},[],{"trials":1009,"activeCount":84},[],{"trials":1011,"activeCount":84},[],{"trials":1013,"activeCount":84},[1014],{"nctId":1015,"briefTitle":1016,"status":232,"phases":1017,"primaryCompletion":1018,"completion":1018,"start":1019,"enrollment":11,"conditions":1020,"interventions":1022},"NCT01978665","The Effect of Prednisone on Physical Exercise in COPD Patients",[76],"2013-12","2013-04",[1021],"Exercise Performance in Copd Patients",[1002],{"trials":1024,"activeCount":84},[],{"intervention":1026,"totalTrials":80,"cells":1027},"Victoza",{"EARLY_PHASE1":1028,"PHASE1":1030,"PHASE2":1032,"PHASE3":1034,"PHASE4":1036,"NA":1048},{"trials":1029,"activeCount":84},[],{"trials":1031,"activeCount":84},[],{"trials":1033,"activeCount":84},[],{"trials":1035,"activeCount":84},[],{"trials":1037,"activeCount":84},[1038],{"nctId":1039,"briefTitle":1040,"status":232,"phases":1041,"primaryCompletion":1042,"completion":1042,"start":1043,"enrollment":224,"conditions":1044,"interventions":1047},"NCT01931982","Effect of Glucagon-like Peptide 1 (GLP-1) on Microvascular Myocardial Function in Patients With Type 2 Diabetes.",[76],"2014-04","2013-05",[1045,1046],"Type 2 Diabetes","Microvascular Dysfunction",[1026],{"trials":1049,"activeCount":84},[],{"intervention":1051,"totalTrials":80,"cells":1052},"methylprednisolon",{"EARLY_PHASE1":1053,"PHASE1":1055,"PHASE2":1057,"PHASE3":1059,"PHASE4":1061,"NA":1073},{"trials":1054,"activeCount":84},[],{"trials":1056,"activeCount":84},[],{"trials":1058,"activeCount":84},[],{"trials":1060,"activeCount":84},[],{"trials":1062,"activeCount":84},[1063],{"nctId":1064,"briefTitle":1065,"status":232,"phases":1066,"primaryCompletion":1067,"completion":1068,"start":1069,"enrollment":545,"conditions":1070,"interventions":1071},"NCT02448316","Plantar Fasciitis, Operation or Conservative Treatment",[76],"2016-11-01","2017-11-01","2015-04-01",[572],[1051,1072],"lidokaine",{"trials":1074,"activeCount":84},[],{"intervention":1072,"totalTrials":80,"cells":1076},{"EARLY_PHASE1":1077,"PHASE1":1079,"PHASE2":1081,"PHASE3":1083,"PHASE4":1085,"NA":1091},{"trials":1078,"activeCount":84},[],{"trials":1080,"activeCount":84},[],{"trials":1082,"activeCount":84},[],{"trials":1084,"activeCount":84},[],{"trials":1086,"activeCount":84},[1087],{"nctId":1064,"briefTitle":1065,"status":232,"phases":1088,"primaryCompletion":1067,"completion":1068,"start":1069,"enrollment":545,"conditions":1089,"interventions":1090},[76],[572],[1051,1072],{"trials":1092,"activeCount":84},[],{"intervention":1094,"totalTrials":80,"cells":1095},"Conventional photodynamic therapy",{"EARLY_PHASE1":1096,"PHASE1":1098,"PHASE2":1100,"PHASE3":1102,"PHASE4":1116,"NA":1118},{"trials":1097,"activeCount":84},[],{"trials":1099,"activeCount":84},[],{"trials":1101,"activeCount":84},[],{"trials":1103,"activeCount":84},[1104],{"nctId":1105,"briefTitle":1106,"status":232,"phases":1107,"primaryCompletion":1108,"completion":1108,"start":1109,"enrollment":1110,"conditions":1111,"interventions":1114},"NCT01260987","Fractional CO2 Laser Assisted Photodynamic Therapy",[74,75],"2012-08","2010-10",47,[1112,1113],"Actinic Keratosis","Basal Cell Carcinoma",[1094,1115],"Fractional CO2 laser assisted PDT",{"trials":1117,"activeCount":84},[],{"trials":1119,"activeCount":84},[],{"intervention":1115,"totalTrials":80,"cells":1121},{"EARLY_PHASE1":1122,"PHASE1":1124,"PHASE2":1126,"PHASE3":1128,"PHASE4":1134,"NA":1136},{"trials":1123,"activeCount":84},[],{"trials":1125,"activeCount":84},[],{"trials":1127,"activeCount":84},[],{"trials":1129,"activeCount":84},[1130],{"nctId":1105,"briefTitle":1106,"status":232,"phases":1131,"primaryCompletion":1108,"completion":1108,"start":1109,"enrollment":1110,"conditions":1132,"interventions":1133},[74,75],[1112,1113],[1094,1115],{"trials":1135,"activeCount":84},[],{"trials":1137,"activeCount":84},[],{"intervention":1139,"totalTrials":80,"cells":1140},"Calcium chloride",{"EARLY_PHASE1":1141,"PHASE1":1143,"PHASE2":1145,"PHASE3":1147,"PHASE4":1157,"NA":1159},{"trials":1142,"activeCount":84},[],{"trials":1144,"activeCount":84},[],{"trials":1146,"activeCount":84},[],{"trials":1148,"activeCount":84},[1149],{"nctId":1150,"briefTitle":1151,"status":542,"phases":1152,"primaryCompletion":1153,"completion":1153,"start":1154,"enrollment":453,"conditions":1155,"interventions":1156},"NCT05046262","Calcium Electroporation for Basal Cell Carcinomas - Proof of Concept Study",[75],"2022-02-22","2020-01-08",[1113],[1139],{"trials":1158,"activeCount":84},[],{"trials":1160,"activeCount":84},[],{"intervention":264,"totalTrials":80,"cells":1162},{"EARLY_PHASE1":1163,"PHASE1":1165,"PHASE2":1167,"PHASE3":1169,"PHASE4":1175,"NA":1177},{"trials":1164,"activeCount":84},[],{"trials":1166,"activeCount":84},[],{"trials":1168,"activeCount":84},[],{"trials":1170,"activeCount":84},[1171],{"nctId":254,"briefTitle":255,"status":232,"phases":1172,"primaryCompletion":257,"completion":258,"start":259,"enrollment":260,"conditions":1173,"interventions":1174},[75],[262],[264,243],{"trials":1176,"activeCount":84},[],{"trials":1178,"activeCount":84},[],{"intervention":1180,"totalTrials":80,"cells":1181},"Melatonin",{"EARLY_PHASE1":1182,"PHASE1":1184,"PHASE2":1186,"PHASE3":1188,"PHASE4":1200,"NA":1202},{"trials":1183,"activeCount":84},[],{"trials":1185,"activeCount":84},[],{"trials":1187,"activeCount":84},[],{"trials":1189,"activeCount":84},[1190],{"nctId":1191,"briefTitle":1192,"status":232,"phases":1193,"primaryCompletion":1194,"completion":1194,"start":1195,"enrollment":1196,"conditions":1197,"interventions":1199},"NCT00925899","Melatonin for Fatigue and Other Symptoms in Patients With Advanced Cancer",[74,75],"2013-03","2009-10",72,[29,1198],"Fatigue",[1180],{"trials":1201,"activeCount":84},[],{"trials":1203,"activeCount":84},[],{"intervention":1205,"totalTrials":80,"cells":1206},"Fluticasone Furoate\u002F Vilanterol Trifenatate",{"EARLY_PHASE1":1207,"PHASE1":1209,"PHASE2":1211,"PHASE3":1223,"PHASE4":1225,"NA":1227},{"trials":1208,"activeCount":84},[],{"trials":1210,"activeCount":84},[],{"trials":1212,"activeCount":84},[1213],{"nctId":1214,"briefTitle":1215,"status":232,"phases":1216,"primaryCompletion":1217,"completion":1217,"start":1218,"enrollment":1219,"conditions":1220,"interventions":1222},"NCT03739294","Urine Concentrations of Vilanterol After Inhaled Administration of Vilanterol\u002FFluticasone Furoate",[74],"2020-12-14","2019-02-08",26,[1221],"Pharmacokinetics",[1205],{"trials":1224,"activeCount":84},[],{"trials":1226,"activeCount":84},[],{"trials":1228,"activeCount":84},[],{"intervention":1230,"totalTrials":80,"cells":1231},"Enstilar",{"EARLY_PHASE1":1232,"PHASE1":1234,"PHASE2":1236,"PHASE3":1248,"PHASE4":1250,"NA":1252},{"trials":1233,"activeCount":84},[],{"trials":1235,"activeCount":84},[],{"trials":1237,"activeCount":84},[1238],{"nctId":1239,"briefTitle":1240,"status":232,"phases":1241,"primaryCompletion":1242,"completion":1242,"start":1243,"enrollment":1244,"conditions":1245,"interventions":1247},"NCT04580537","Assessing the Efficacy of Image-guided Laser-assisted Enstilar® Delivery for Treatment of Psoriatic Nails",[74],"2021-06-01","2020-10-02",11,[1246],"Nail Psoriasis",[1230],{"trials":1249,"activeCount":84},[],{"trials":1251,"activeCount":84},[],{"trials":1253,"activeCount":84},[],{"intervention":1255,"totalTrials":80,"cells":1256},"Roflumilast",{"EARLY_PHASE1":1257,"PHASE1":1259,"PHASE2":1261,"PHASE3":1273,"PHASE4":1275,"NA":1277},{"trials":1258,"activeCount":84},[],{"trials":1260,"activeCount":84},[],{"trials":1262,"activeCount":84},[1263],{"nctId":1264,"briefTitle":1265,"status":232,"phases":1266,"primaryCompletion":1267,"completion":1267,"start":1268,"enrollment":1269,"conditions":1270,"interventions":1272},"NCT04549870","Efficacy of Roflumilast in the Treatment of Psoriasis",[74],"2022-12-12","2021-01-01",46,[1271],"Psoriasis",[1255],{"trials":1274,"activeCount":84},[],{"trials":1276,"activeCount":84},[],{"trials":1278,"activeCount":84},[],{"intervention":1280,"totalTrials":80,"cells":1281},"MAL Control.",{"EARLY_PHASE1":1282,"PHASE1":1284,"PHASE2":1295,"PHASE3":1297,"PHASE4":1299,"NA":1301},{"trials":1283,"activeCount":84},[],{"trials":1285,"activeCount":84},[1286],{"nctId":1287,"briefTitle":1288,"status":232,"phases":1289,"primaryCompletion":1290,"completion":1290,"start":1290,"enrollment":1291,"conditions":1292,"interventions":1294},"NCT02372370","Pretreatments of the Skin Prior to PDT",[73],"2014-12",12,[1293],"Healthy",[1280],{"trials":1296,"activeCount":84},[],{"trials":1298,"activeCount":84},[],{"trials":1300,"activeCount":84},[],{"trials":1302,"activeCount":84},[],{"intervention":1304,"totalTrials":80,"cells":1305},"glucosamine sulphate",{"EARLY_PHASE1":1306,"PHASE1":1308,"PHASE2":1322,"PHASE3":1324,"PHASE4":1326,"NA":1328},{"trials":1307,"activeCount":84},[],{"trials":1309,"activeCount":84},[1310],{"nctId":1311,"briefTitle":1312,"status":542,"phases":1313,"primaryCompletion":1314,"completion":1315,"start":1316,"enrollment":1317,"conditions":1318,"interventions":1320},"NCT00833157","Effect of Glucosamine or Ibuprofen Combined With Physical Training in Patients With Knee-Osteoarthritis",[73],"2007-07","2009-03","2005-02",36,[1319],"Osteoarthritis of the Knee",[1304,1321],"ibuprofen",{"trials":1323,"activeCount":84},[],{"trials":1325,"activeCount":84},[],{"trials":1327,"activeCount":84},[],{"trials":1329,"activeCount":84},[],{"intervention":1321,"totalTrials":80,"cells":1331},{"EARLY_PHASE1":1332,"PHASE1":1334,"PHASE2":1340,"PHASE3":1342,"PHASE4":1344,"NA":1346},{"trials":1333,"activeCount":84},[],{"trials":1335,"activeCount":84},[1336],{"nctId":1311,"briefTitle":1312,"status":542,"phases":1337,"primaryCompletion":1314,"completion":1315,"start":1316,"enrollment":1317,"conditions":1338,"interventions":1339},[73],[1319],[1304,1321],{"trials":1341,"activeCount":84},[],{"trials":1343,"activeCount":84},[],{"trials":1345,"activeCount":84},[],{"trials":1347,"activeCount":84},[],{"intervention":1349,"totalTrials":80,"cells":1350},"Ketone",{"EARLY_PHASE1":1351,"PHASE1":1353,"PHASE2":1367,"PHASE3":1369,"PHASE4":1371,"NA":1373},{"trials":1352,"activeCount":84},[],{"trials":1354,"activeCount":84},[1355],{"nctId":1356,"briefTitle":1357,"status":232,"phases":1358,"primaryCompletion":1359,"completion":1359,"start":1360,"enrollment":497,"conditions":1361,"interventions":1365},"NCT03657537","Effects of Ketone Bodies on Cognition in Type 2 Diabetes",[73],"2019-02-14","2018-09-17",[1362,1363,1364],"Type2 Diabetes","Ketonemia","Cognitive Change",[1349,1366],"Saline",{"trials":1368,"activeCount":84},[],{"trials":1370,"activeCount":84},[],{"trials":1372,"activeCount":84},[],{"trials":1374,"activeCount":84},[],{"intervention":1376,"totalTrials":80,"cells":1377},"Nivolumab 10 MG\u002FML",{"EARLY_PHASE1":1378,"PHASE1":1393,"PHASE2":1395,"PHASE3":1397,"PHASE4":1399,"NA":1401},{"trials":1379,"activeCount":84},[1380],{"nctId":1381,"briefTitle":1382,"status":542,"phases":1383,"primaryCompletion":1384,"completion":1385,"start":1386,"enrollment":545,"conditions":1387,"interventions":1392},"NCT04570683","Laser Immunotherapy With and Without Topical Anti-PD1 in Basal Cell Carcinomas",[72],"2021-09","2021-11","2020-01-27",[1388,1389,1390,1391],"BCC - Basal Cell Carcinoma","Immune Response","Immunotherapy","Ablative Fractionated Laser",[1376],{"trials":1394,"activeCount":84},[],{"trials":1396,"activeCount":84},[],{"trials":1398,"activeCount":84},[],{"trials":1400,"activeCount":84},[],{"trials":1402,"activeCount":84},[],{"intervention":1404,"totalTrials":80,"cells":1405},"Low-dose rhEpo",{"EARLY_PHASE1":1406,"PHASE1":1418,"PHASE2":1420,"PHASE3":1422,"PHASE4":1424,"NA":1426},{"trials":1407,"activeCount":84},[1408],{"nctId":1409,"briefTitle":1410,"status":232,"phases":1411,"primaryCompletion":1412,"completion":1412,"start":1413,"enrollment":453,"conditions":1414,"interventions":1416},"NCT03093506","Effects of Micro-dose and Low-dose Recombinant Human Erythropoietin on Mitochondrial Function and Cognitive Performance",[72],"2011-12","2011-09",[1415],"Human Volunteers",[1404,1417],"Micro-dose rhEpo",{"trials":1419,"activeCount":84},[],{"trials":1421,"activeCount":84},[],{"trials":1423,"activeCount":84},[],{"trials":1425,"activeCount":84},[],{"trials":1427,"activeCount":84},[],{"intervention":1417,"totalTrials":80,"cells":1429},{"EARLY_PHASE1":1430,"PHASE1":1436,"PHASE2":1438,"PHASE3":1440,"PHASE4":1442,"NA":1444},{"trials":1431,"activeCount":84},[1432],{"nctId":1409,"briefTitle":1410,"status":232,"phases":1433,"primaryCompletion":1412,"completion":1412,"start":1413,"enrollment":453,"conditions":1434,"interventions":1435},[72],[1415],[1404,1417],{"trials":1437,"activeCount":84},[],{"trials":1439,"activeCount":84},[],{"trials":1441,"activeCount":84},[],{"trials":1443,"activeCount":84},[],{"trials":1445,"activeCount":84},[],{"intervention":1447,"totalTrials":80,"cells":1448},"Insulin-like growth factor I",{"EARLY_PHASE1":1449,"PHASE1":1459,"PHASE2":1461,"PHASE3":1463,"PHASE4":1465,"NA":1467},{"trials":1450,"activeCount":84},[1451],{"nctId":1452,"briefTitle":1453,"status":542,"phases":1454,"primaryCompletion":1455,"completion":1456,"start":1019,"enrollment":260,"conditions":1457,"interventions":1458},"NCT01834989","Patellar Tendinopathy - Effect of Training and Enhancement of the Collagen Synthesis by Insulin-like Growth Factor-I",[72],"2017-02-01","2020-12-01",[24],[1447],{"trials":1460,"activeCount":84},[],{"trials":1462,"activeCount":84},[],{"trials":1464,"activeCount":84},[],{"trials":1466,"activeCount":84},[],{"trials":1468,"activeCount":84},[],{"intervention":1366,"totalTrials":1470,"cells":1471},4,{"EARLY_PHASE1":1472,"PHASE1":1474,"PHASE2":1480,"PHASE3":1482,"PHASE4":1484,"NA":1498},{"trials":1473,"activeCount":84},[],{"trials":1475,"activeCount":84},[1476],{"nctId":1356,"briefTitle":1357,"status":232,"phases":1477,"primaryCompletion":1359,"completion":1359,"start":1360,"enrollment":497,"conditions":1478,"interventions":1479},[73],[1362,1363,1364],[1349,1366],{"trials":1481,"activeCount":84},[],{"trials":1483,"activeCount":84},[],{"trials":1485,"activeCount":84},[1486],{"nctId":1487,"briefTitle":1488,"status":542,"phases":1489,"primaryCompletion":1490,"completion":1491,"start":1492,"enrollment":595,"conditions":1493,"interventions":1495},"NCT01326039","Ultrasound-guided Ilioinguinal-iliohypogastric Block for Inguinal Hernia Repair",[76],"2011-06","2011-07","2010-05",[1494],"Inguinal Hernia",[1496,1497],"bupivacaine","saline",{"trials":1499,"activeCount":84},[1500,1512],{"nctId":1501,"briefTitle":1502,"status":542,"phases":1503,"primaryCompletion":1504,"completion":1504,"start":1505,"enrollment":1506,"conditions":1507,"interventions":1509},"NCT01276925","Total Hip Arthroplasty: Multiple Blocks by UltraSound",[77],"2016-05","2011-08",81,[1508],"Pain, Postoperative",[1510,1510,1366,1511],"Ropivacaine","Bupivacaine",{"nctId":1513,"briefTitle":1514,"status":232,"phases":1515,"primaryCompletion":1516,"completion":1516,"start":1413,"enrollment":357,"conditions":1517,"interventions":1519},"NCT01446783","IGF-I Stimulation of Collagen Synthesis in Ehlers-Danlos Patients",[77],"2012-11",[1518],"Ehlers-Danlos Syndrome, Classic",[1520,1366],"mecasermin",{"intervention":1510,"totalTrials":1522,"cells":1523},3,{"EARLY_PHASE1":1524,"PHASE1":1526,"PHASE2":1528,"PHASE3":1530,"PHASE4":1532,"NA":1534},{"trials":1525,"activeCount":84},[],{"trials":1527,"activeCount":84},[],{"trials":1529,"activeCount":84},[],{"trials":1531,"activeCount":84},[],{"trials":1533,"activeCount":84},[],{"trials":1535,"activeCount":84},[1536,1545,1554],{"nctId":1537,"briefTitle":1538,"status":232,"phases":1539,"primaryCompletion":1018,"completion":1018,"start":943,"enrollment":1540,"conditions":1541,"interventions":1543},"NCT01825863","Ultrasound-guided Abdominal Wall Nerve Blockade in Laparoscopic Surgery for Acute Appendicitis.",[77],56,[1542],"Appendicitis",[1510,1544],"Saline 9%",{"nctId":1546,"briefTitle":1547,"status":542,"phases":1548,"primaryCompletion":1549,"completion":1549,"start":1550,"enrollment":1291,"conditions":1551,"interventions":1553},"NCT04764045","The Significance of Peripheral Input",[77],"2021-05-01","2019-11-20",[1552],"Neuropathic Pain",[1510],{"nctId":1501,"briefTitle":1502,"status":542,"phases":1555,"primaryCompletion":1504,"completion":1504,"start":1505,"enrollment":1506,"conditions":1556,"interventions":1557},[77],[1508],[1510,1510,1366,1511],{"intervention":1511,"totalTrials":1522,"cells":1559},{"EARLY_PHASE1":1560,"PHASE1":1562,"PHASE2":1564,"PHASE3":1566,"PHASE4":1568,"NA":1574},{"trials":1561,"activeCount":84},[],{"trials":1563,"activeCount":84},[],{"trials":1565,"activeCount":84},[],{"trials":1567,"activeCount":84},[],{"trials":1569,"activeCount":84},[1570],{"nctId":1487,"briefTitle":1488,"status":542,"phases":1571,"primaryCompletion":1490,"completion":1491,"start":1492,"enrollment":595,"conditions":1572,"interventions":1573},[76],[1494],[1496,1497],{"trials":1575,"activeCount":84},[1576,1583],{"nctId":1577,"briefTitle":1578,"status":232,"phases":1579,"primaryCompletion":1019,"completion":1019,"start":1580,"enrollment":272,"conditions":1581,"interventions":1582},"NCT01305603","Ultrasound-guided Dual TAP Block: Magnetic Resonance (MR) Evaluation of the Distribution of Local Anesthetic",[77],"2011-02",[1508],[1511],{"nctId":1501,"briefTitle":1502,"status":542,"phases":1584,"primaryCompletion":1504,"completion":1504,"start":1505,"enrollment":1506,"conditions":1585,"interventions":1586},[77],[1508],[1510,1510,1366,1511],{"intervention":1588,"totalTrials":80,"cells":1589},"ALK Grazax 75,000 SQ-T \"Phleum pratense\"",{"EARLY_PHASE1":1590,"PHASE1":1592,"PHASE2":1594,"PHASE3":1596,"PHASE4":1598,"NA":1600},{"trials":1591,"activeCount":84},[],{"trials":1593,"activeCount":84},[],{"trials":1595,"activeCount":84},[],{"trials":1597,"activeCount":84},[],{"trials":1599,"activeCount":84},[],{"trials":1601,"activeCount":84},[1602],{"nctId":1603,"briefTitle":1604,"status":232,"phases":1605,"primaryCompletion":1108,"completion":1108,"start":1606,"enrollment":260,"conditions":1607,"interventions":1609},"NCT01889875","Immunological Comparison of AIT and SCIT Immunotherapy Against Grass Pollen",[77],"2010-11",[1608],"Allergic Rhinitis Due to Grass Pollens",[1588,1610],"ALK AluTard 225 \"Phleum pratense\"",{"intervention":1610,"totalTrials":80,"cells":1612},{"EARLY_PHASE1":1613,"PHASE1":1615,"PHASE2":1617,"PHASE3":1619,"PHASE4":1621,"NA":1623},{"trials":1614,"activeCount":84},[],{"trials":1616,"activeCount":84},[],{"trials":1618,"activeCount":84},[],{"trials":1620,"activeCount":84},[],{"trials":1622,"activeCount":84},[],{"trials":1624,"activeCount":84},[1625],{"nctId":1603,"briefTitle":1604,"status":232,"phases":1626,"primaryCompletion":1108,"completion":1108,"start":1606,"enrollment":260,"conditions":1627,"interventions":1628},[77],[1608],[1588,1610],{"intervention":1630,"totalTrials":80,"cells":1631},"Specific immunotherapy",{"EARLY_PHASE1":1632,"PHASE1":1634,"PHASE2":1636,"PHASE3":1638,"PHASE4":1640,"NA":1642},{"trials":1633,"activeCount":84},[],{"trials":1635,"activeCount":84},[],{"trials":1637,"activeCount":84},[],{"trials":1639,"activeCount":84},[],{"trials":1641,"activeCount":84},[],{"trials":1643,"activeCount":84},[1644],{"nctId":1645,"briefTitle":1646,"status":542,"phases":1647,"completion":495,"start":1648,"enrollment":260,"conditions":1649,"interventions":1653},"NCT00312312","Allergy Towards Grass and Bronchial Inflammation - Related to Immunotherapy and Exhaled Nitrogen Oxide",[77],"2006-03",[1650,1651,1652],"Asthma, Bronchial","Allergic Rhinitis","Hypersensitivity, Immediate",[1630],{"intervention":1655,"totalTrials":80,"cells":1656},"Change to dose of patient's regular medication",{"EARLY_PHASE1":1657,"PHASE1":1659,"PHASE2":1661,"PHASE3":1663,"PHASE4":1665,"NA":1667},{"trials":1658,"activeCount":84},[],{"trials":1660,"activeCount":84},[],{"trials":1662,"activeCount":84},[],{"trials":1664,"activeCount":84},[],{"trials":1666,"activeCount":84},[],{"trials":1668,"activeCount":84},[1669],{"nctId":1670,"briefTitle":1671,"status":232,"phases":1672,"primaryCompletion":1673,"completion":1673,"start":1674,"enrollment":19,"conditions":1675,"interventions":1676},"NCT03321877","Down-titration of Steroids in Patients With Difficult Asthma With no Bronchial Hyperreactivity",[77],"2017-05-31","2016-10-01",[15],[1655],{"intervention":1678,"totalTrials":80,"cells":1679},"Diltiazem",{"EARLY_PHASE1":1680,"PHASE1":1682,"PHASE2":1684,"PHASE3":1686,"PHASE4":1688,"NA":1690},{"trials":1681,"activeCount":84},[],{"trials":1683,"activeCount":84},[],{"trials":1685,"activeCount":84},[],{"trials":1687,"activeCount":84},[],{"trials":1689,"activeCount":84},[],{"trials":1691,"activeCount":84},[1692],{"nctId":1693,"briefTitle":1694,"status":695,"phases":1695,"primaryCompletion":1696,"completion":1696,"start":1697,"enrollment":1698,"conditions":1699,"interventions":1701},"NCT02158013","Treatment Of Chronic Anal Fissure",[77],"2018-02-05","2014-09-01",55,[1700],"Chronic Anal Fissure",[1678],{"intervention":1544,"totalTrials":80,"cells":1703},{"EARLY_PHASE1":1704,"PHASE1":1706,"PHASE2":1708,"PHASE3":1710,"PHASE4":1712,"NA":1714},{"trials":1705,"activeCount":84},[],{"trials":1707,"activeCount":84},[],{"trials":1709,"activeCount":84},[],{"trials":1711,"activeCount":84},[],{"trials":1713,"activeCount":84},[],{"trials":1715,"activeCount":84},[1716],{"nctId":1537,"briefTitle":1538,"status":232,"phases":1717,"primaryCompletion":1018,"completion":1018,"start":943,"enrollment":1540,"conditions":1718,"interventions":1719},[77],[1542],[1510,1544],{"intervention":1721,"totalTrials":80,"cells":1722},"Medication",{"EARLY_PHASE1":1723,"PHASE1":1725,"PHASE2":1727,"PHASE3":1729,"PHASE4":1731,"NA":1733},{"trials":1724,"activeCount":84},[],{"trials":1726,"activeCount":84},[],{"trials":1728,"activeCount":84},[],{"trials":1730,"activeCount":84},[],{"trials":1732,"activeCount":84},[],{"trials":1734,"activeCount":84},[1735],{"nctId":1736,"briefTitle":1737,"status":232,"phases":1738,"primaryCompletion":1739,"completion":1739,"start":1740,"enrollment":1741,"conditions":1742,"interventions":1745},"NCT02910154","Comprehensive Treatment of Angina in Women With Microvascular Dysfunction",[77],"2018-10-01","2016-12",62,[1743,1744],"Angina Pectoris","Coronary Microvascular Disease",[1721],{"intervention":1747,"totalTrials":80,"cells":1748},"Cortico-Steroid Injection. Depomedrol 40mg\u002F1ml.",{"EARLY_PHASE1":1749,"PHASE1":1751,"PHASE2":1753,"PHASE3":1755,"PHASE4":1757,"NA":1759},{"trials":1750,"activeCount":84},[],{"trials":1752,"activeCount":84},[],{"trials":1754,"activeCount":84},[],{"trials":1756,"activeCount":84},[],{"trials":1758,"activeCount":84},[],{"trials":1760,"activeCount":84},[1761],{"nctId":1762,"briefTitle":1763,"status":232,"phases":1764,"primaryCompletion":1765,"completion":1765,"start":1766,"enrollment":595,"conditions":1767,"interventions":1769},"NCT02521298","Treatment of Lateral Elbow Tendinopathy",[77],"2020-04-05","2015-10",[1768],"Epicondylitis, Lateral Humeral",[1747],{"intervention":1771,"totalTrials":80,"cells":1772},"High Volume injection without corticosteroid",{"EARLY_PHASE1":1773,"PHASE1":1775,"PHASE2":1777,"PHASE3":1779,"PHASE4":1781,"NA":1783},{"trials":1774,"activeCount":84},[],{"trials":1776,"activeCount":84},[],{"trials":1778,"activeCount":84},[],{"trials":1780,"activeCount":84},[],{"trials":1782,"activeCount":84},[],{"trials":1784,"activeCount":84},[1785],{"nctId":1786,"briefTitle":1787,"status":232,"phases":1788,"primaryCompletion":1789,"completion":1290,"start":1018,"enrollment":1790,"conditions":1791,"interventions":1792},"NCT02839577","The Effect of High Volume Injection With and Without Steroid in Chronic Achilles Tendinopathy",[77],"2014-07",28,[24],[1771,1793],"High Volume injection with corticosteroid",{"intervention":1793,"totalTrials":80,"cells":1795},{"EARLY_PHASE1":1796,"PHASE1":1798,"PHASE2":1800,"PHASE3":1802,"PHASE4":1804,"NA":1806},{"trials":1797,"activeCount":84},[],{"trials":1799,"activeCount":84},[],{"trials":1801,"activeCount":84},[],{"trials":1803,"activeCount":84},[],{"trials":1805,"activeCount":84},[],{"trials":1807,"activeCount":84},[1808],{"nctId":1786,"briefTitle":1787,"status":232,"phases":1809,"primaryCompletion":1789,"completion":1290,"start":1018,"enrollment":1790,"conditions":1810,"interventions":1811},[77],[24],[1771,1793],{"intervention":1813,"totalTrials":80,"cells":1814},"Usual care versus primary care",{"EARLY_PHASE1":1815,"PHASE1":1817,"PHASE2":1819,"PHASE3":1821,"PHASE4":1823,"NA":1825},{"trials":1816,"activeCount":84},[],{"trials":1818,"activeCount":84},[],{"trials":1820,"activeCount":84},[],{"trials":1822,"activeCount":84},[],{"trials":1824,"activeCount":84},[],{"trials":1826,"activeCount":84},[1827],{"nctId":1828,"briefTitle":1829,"status":232,"phases":1830,"primaryCompletion":1831,"completion":1832,"start":1833,"enrollment":1834,"conditions":1835,"interventions":1836},"NCT04727112","Asthma and Allergy Screening AA2000 (Cross Sectional)",[],"2003-01","2004-01","2000-01",493,[15],[1813],{"intervention":1838,"totalTrials":80,"cells":1839},"Pulmicort",{"EARLY_PHASE1":1840,"PHASE1":1842,"PHASE2":1844,"PHASE3":1846,"PHASE4":1848,"NA":1850},{"trials":1841,"activeCount":84},[],{"trials":1843,"activeCount":84},[],{"trials":1845,"activeCount":84},[],{"trials":1847,"activeCount":84},[],{"trials":1849,"activeCount":84},[],{"trials":1851,"activeCount":84},[1852],{"nctId":1853,"briefTitle":1854,"status":232,"phases":1855,"primaryCompletion":1856,"completion":1856,"start":1516,"enrollment":1857,"conditions":1858,"interventions":1859},"NCT01978678","Does Asthma Phenotype Have Impact on Disease Control",[],"2015-01",80,[15],[1838],{"intervention":1861,"totalTrials":80,"cells":1862},"salbutamol",{"EARLY_PHASE1":1863,"PHASE1":1865,"PHASE2":1867,"PHASE3":1869,"PHASE4":1871,"NA":1873},{"trials":1864,"activeCount":84},[],{"trials":1866,"activeCount":84},[],{"trials":1868,"activeCount":84},[],{"trials":1870,"activeCount":84},[],{"trials":1872,"activeCount":84},[],{"trials":1874,"activeCount":84},[1875],{"nctId":1876,"briefTitle":1877,"status":542,"phases":1878,"primaryCompletion":1108,"completion":1879,"start":1505,"enrollment":224,"conditions":1880,"interventions":1882},"NCT01415596","The Effect of High Dose Salbutamol on Muscle Performance",[77],"2013-08",[1881],"Ergogenic Effects of Salbutamol in Healthy Males",[1861],{"intervention":1884,"totalTrials":80,"cells":1885},"High Volume",{"EARLY_PHASE1":1886,"PHASE1":1888,"PHASE2":1890,"PHASE3":1892,"PHASE4":1894,"NA":1896},{"trials":1887,"activeCount":84},[],{"trials":1889,"activeCount":84},[],{"trials":1891,"activeCount":84},[],{"trials":1893,"activeCount":84},[],{"trials":1895,"activeCount":84},[],{"trials":1897,"activeCount":84},[1898],{"nctId":1899,"briefTitle":1900,"status":232,"phases":1901,"primaryCompletion":415,"completion":1902,"start":1903,"enrollment":595,"conditions":1904,"interventions":1905},"NCT02417987","High Volume Injection or Autologous Conditioned Plasma (ACP) in Chronic Achilles Tendinopathy",[77],"2014-11","2012-05",[24],[1884,1906],"Autologous conditioned plasma",{"intervention":1906,"totalTrials":80,"cells":1908},{"EARLY_PHASE1":1909,"PHASE1":1911,"PHASE2":1913,"PHASE3":1915,"PHASE4":1917,"NA":1919},{"trials":1910,"activeCount":84},[],{"trials":1912,"activeCount":84},[],{"trials":1914,"activeCount":84},[],{"trials":1916,"activeCount":84},[],{"trials":1918,"activeCount":84},[],{"trials":1920,"activeCount":84},[1921],{"nctId":1899,"briefTitle":1900,"status":232,"phases":1922,"primaryCompletion":415,"completion":1902,"start":1903,"enrollment":595,"conditions":1923,"interventions":1924},[77],[24],[1884,1906],{"intervention":1926,"totalTrials":80,"cells":1927},"NSAID",{"EARLY_PHASE1":1928,"PHASE1":1930,"PHASE2":1932,"PHASE3":1934,"PHASE4":1936,"NA":1938},{"trials":1929,"activeCount":84},[],{"trials":1931,"activeCount":84},[],{"trials":1933,"activeCount":84},[],{"trials":1935,"activeCount":84},[],{"trials":1937,"activeCount":84},[],{"trials":1939,"activeCount":84},[1940],{"nctId":1941,"briefTitle":1942,"status":232,"phases":1943,"primaryCompletion":1944,"completion":1944,"start":1945,"enrollment":1946,"conditions":1947,"interventions":1949},"NCT00832663","Influence of Non-steroidal Anti-inflammatory Drugs (NSAID) on Muscle Regeneration",[77],"2009-12","2009-04",32,[1948],"Muscle Damage",[1926],{"intervention":1951,"totalTrials":80,"cells":1952},"physostigmine",{"EARLY_PHASE1":1953,"PHASE1":1955,"PHASE2":1957,"PHASE3":1959,"PHASE4":1961,"NA":1963},{"trials":1954,"activeCount":84},[],{"trials":1956,"activeCount":84},[],{"trials":1958,"activeCount":84},[],{"trials":1960,"activeCount":84},[],{"trials":1962,"activeCount":84},[],{"trials":1964,"activeCount":84},[1965],{"nctId":1966,"briefTitle":1967,"status":542,"phases":1968,"primaryCompletion":544,"completion":1969,"start":1944,"enrollment":295,"conditions":1970,"interventions":1973},"NCT00850850","Physostigmine After General Anesthesia",[77],"2011-05",[1971,1972],"Postoperative Nausea and Vomiting","Anesthesia Recovery Period",[1951,1974],"Isotonic sodium chloride solution",{"intervention":1974,"totalTrials":80,"cells":1976},{"EARLY_PHASE1":1977,"PHASE1":1979,"PHASE2":1981,"PHASE3":1983,"PHASE4":1985,"NA":1987},{"trials":1978,"activeCount":84},[],{"trials":1980,"activeCount":84},[],{"trials":1982,"activeCount":84},[],{"trials":1984,"activeCount":84},[],{"trials":1986,"activeCount":84},[],{"trials":1988,"activeCount":84},[1989],{"nctId":1966,"briefTitle":1967,"status":542,"phases":1990,"primaryCompletion":544,"completion":1969,"start":1944,"enrollment":295,"conditions":1991,"interventions":1992},[77],[1971,1972],[1951,1974],{"intervention":1994,"totalTrials":80,"cells":1995},"corticosteroids",{"EARLY_PHASE1":1996,"PHASE1":1998,"PHASE2":2000,"PHASE3":2002,"PHASE4":2004,"NA":2006},{"trials":1997,"activeCount":84},[],{"trials":1999,"activeCount":84},[],{"trials":2001,"activeCount":84},[],{"trials":2003,"activeCount":84},[],{"trials":2005,"activeCount":84},[],{"trials":2007,"activeCount":84},[2008],{"nctId":2009,"briefTitle":2010,"status":542,"phases":2011,"start":496,"enrollment":224,"conditions":2012,"interventions":2014},"NCT00206882","The Sun Protection Effect and Efficacy in Treatment of Sunburn Using Topical Corticosteroids.",[77],[2013],"Sunburn",[1994],{"intervention":2016,"totalTrials":80,"cells":2017},"Transdermal nicotine patch",{"EARLY_PHASE1":2018,"PHASE1":2020,"PHASE2":2022,"PHASE3":2024,"PHASE4":2026,"NA":2028},{"trials":2019,"activeCount":84},[],{"trials":2021,"activeCount":84},[],{"trials":2023,"activeCount":84},[],{"trials":2025,"activeCount":84},[],{"trials":2027,"activeCount":84},[],{"trials":2029,"activeCount":84},[2030],{"nctId":2031,"briefTitle":2032,"status":232,"phases":2033,"primaryCompletion":2034,"completion":2035,"start":2036,"enrollment":417,"conditions":2037,"interventions":2039},"NCT00825851","Effect of Smoking, Abstention and Nicotine Replacement Therapy on Wound Healing",[77],"2000-12","2001-01","2000-08",[2038],"Wound Healing",[2016],{"intervention":2041,"totalTrials":80,"cells":2042},"OPTIMAL algorithm",{"EARLY_PHASE1":2043,"PHASE1":2045,"PHASE2":2047,"PHASE3":2049,"PHASE4":2051,"NA":2053},{"trials":2044,"activeCount":84},[],{"trials":2046,"activeCount":84},[],{"trials":2048,"activeCount":84},[],{"trials":2050,"activeCount":84},[],{"trials":2052,"activeCount":84},[],{"trials":2054,"activeCount":84},[2055],{"nctId":2056,"briefTitle":2057,"status":542,"phases":2058,"primaryCompletion":2059,"completion":2060,"start":1268,"enrollment":768,"conditions":2061,"interventions":2062},"NCT04648761","Individualized Titration of Biologics in Severe Asthma",[77],"2022-10-01","2023-10-01",[15],[2041],{"intervention":1520,"totalTrials":80,"cells":2064},{"EARLY_PHASE1":2065,"PHASE1":2067,"PHASE2":2069,"PHASE3":2071,"PHASE4":2073,"NA":2075},{"trials":2066,"activeCount":84},[],{"trials":2068,"activeCount":84},[],{"trials":2070,"activeCount":84},[],{"trials":2072,"activeCount":84},[],{"trials":2074,"activeCount":84},[],{"trials":2076,"activeCount":84},[2077],{"nctId":1513,"briefTitle":1514,"status":232,"phases":2078,"primaryCompletion":1516,"completion":1516,"start":1413,"enrollment":357,"conditions":2079,"interventions":2080},[77],[1518],[1520,1366],{"intervention":2082,"totalTrials":80,"cells":2083},"Standard-of-care medical treatment",{"EARLY_PHASE1":2084,"PHASE1":2086,"PHASE2":2088,"PHASE3":2090,"PHASE4":2092,"NA":2094},{"trials":2085,"activeCount":84},[],{"trials":2087,"activeCount":84},[],{"trials":2089,"activeCount":84},[],{"trials":2091,"activeCount":84},[],{"trials":2093,"activeCount":84},[],{"trials":2095,"activeCount":84},[2096],{"nctId":2097,"briefTitle":2098,"status":232,"phases":2099,"primaryCompletion":2100,"completion":2101,"start":2102,"enrollment":2103,"conditions":2104,"interventions":2107},"NCT05017753","Thoracentesis to Alleviate Cardiac Pleural Effusion",[77],"2024-03-22","2024-12-11","2021-08-31",135,[2105,2106],"Heart Failure","Pleural Effusion",[2082]]